HEMZX | VEMIX | HEMZX / VEMIX | |
Total Expense Ratio | 1.48 | 0.09 | 1,644% |
Annual Report Gross Expense Ratio | 1.67 | 0.09 | 1,856% |
Fund Existence | 26 years | 25 years | - |
Gain YTD | 19.614 | 20.722 | 95% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 5000000 | 0% |
Min. Initial Investment IRA | 100 | N/A | - |
Net Assets | 527M | 130B | 0% |
Annual Yield % from dividends | 0.00 | 2.68 | - |
Returns for 1 year | 12.59 | 22.68 | 55% |
Returns for 3 years | 5.92 | 41.04 | 14% |
Returns for 5 years | -25.83 | 34.94 | -74% |
Returns for 10 years | -2.01 | 83.36 | -2% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PSFM | 31.06 | 0.01 | +0.04% |
Pacer Swan SOS Flex (April) ETF | |||
JHI | 14.17 | N/A | -0.03% |
John Hancock Investors Trust Capital Stock | |||
ENDW | 30.19 | -0.06 | -0.19% |
Cambria Endowment Style ETF | |||
EMHY | 39.91 | -0.12 | -0.30% |
iShares J.P. Morgan EM High Yld Bd ETF | |||
IHI | 61.27 | -0.51 | -0.83% |
iShares US Medical Devices ETF |